MSLE

About Satellos Bioscience Inc. Common Stock (MSLE) Stock

Satellos Bioscience Inc. Common Stock (MSLE) closed the 2026-09-16 session at $9.30, down 0.64% versus the previous close (-0.06). The stock opened at $9.50 and traded between $9.19 and $9.66 during that session. Session trading volume was 30K shares. The volume-weighted average price (VWAP) is $9.45.

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience Inc. Common Stock has a market capitalization of $198.6 million. MSLE is listed on the XNAS exchange. The company employs approximately 21 people. The recorded listing date is 2021-08-18.

On this page you can find market MSLE stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.